Skip to main content

Table 1 Demographic data of controls and type 2 diabetes

From: Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains

Healthy individuals (N = 34)

 

Gender

 

Age

 

BMI: normal: < 24.9; overweight: > 25

%; median; STD

Age-controlled healthy individuals (n = 17)

 F: 82%; M: 18%

 

61 (± 11)

 

< 24.9: 47%; > 25: 53%

Young healthy individuals (n = 17)

 F: 24% M: 76%

 

22 (± 4)

 

< 24.9: 88%; > 25: 12%

Type 2 diabetes individuals (N = 33; BMI: > 25)

 

Gender

Age

HbA1c (%)

Chol (mMol L−1)

% with dyslipidaemia (%)

% with hypertension (%)

% with using anti-coagulants (%)

%; median; STD

F: 39% M: 61%

62 (± 11)

7 (± 1.2)

3.95 (± 0.74)

79

61

55

  1. Statistical analysis was performed with the Mann–Whitney U test, using the STATSDIRECT (version 2.8.0) software
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840